In light of these data, a probability scale with 80% sensitivity and 82.5% specificity (including sex, ALT, HOMA-IR, and TyG) that can be used in the diagnosis of NAFLD was proposed. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.